Development of combination strategies for Focal Adhesion Kinase inhibition in Diffuse Gastric Cancer.
Ke PengFeifei ZhangYichen WangPranshu SahgalTianxia LiJin ZhouXiaoyan LiangYanxi ZhangNilay S SethiTian-Shu LiuHaisheng ZhangAdam J BassPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Our data suggest that FAK inhibitors combined with MAPK inhibitors or CDK4/6 inhibitors warrant further testing in clinical trials for DGC.